Close
Novotech
Jabsco PureFlo 21 Single Use

News

Pelican BioThermal Partnership with Asiana Airlines Announced

Pelican BioThermal, the global name in temperature controlled packaging, announces its latest partnership with Asiana Airlines, which will see an extensive expansion of the company’s growing global network. In the ongoing rapid response to support the global fight against COVID-19,...

Enara and Boehringer Ingelheim sign oncology partnership

Enara and Boehringer Ingelheim have teamed up to discover and develop novel cancer immunotherapies against overlooked dark antigen targets. How could dark antigens improve the treatment of solid tumour cancers. UK-based Enara Bio has entered into a collaboration with German-headquartered...

CDSCO panel recommends approval for trial of Bharat Biotechs nasal vaccine

Indian drug regulator CDSCO’s subject expert committee has recommended granting permission for conducting Phase I clinical trial of Bharat Biotech’s intranasal Covid-19 vaccine (BBV154). Preclinical testing of the intranasal vaccine for toxicology, immunogenicity and challenge studies carried out in the...

Nexelis acquires the GSK vaccines clinical bioanalytical laboratory located in Germany

Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider of advanced assay development and laboratory testing services in the infectious, oncologic, and metabolic diseases fields, has signed an asset purchase agreement with GSK to acquire its...

Lilly, Merus Ink Up-to-$1.6B Bispecific Antibody Partnership vs. Cancer

Eli Lilly’s oncology-focused Loxo Oncology at Lilly will partner with Merus to develop up to three CD3-engaging T-cell re-directing bispecific antibody therapies, through a research collaboration and exclusive licensing agreement that could generate up to $1.6 billion for the...

CPhI & P-MEC China gives a glimpse of the success returning pharma events will deliver in 2021

The recently hosted CPhI & P-MEC China 2020 – organized by Informa Markets and CCCMHPIE and co-organized by Shanghai Sinoexpo Informa Markets International Exhibition Co., Ltd. – attracted a remarkable 46,157 visits of professional pharma visitors, including 5,105 international...

ConserV Bioscience and Lawrence Livermore National Laboratory to Collaborate on Development of Broad-spectrum Coronavirus Vaccine

ConserV Bioscience Limited (“ConserV”), a clinical-stage biotechnology company focused on developing vaccines that protect against endemic and emergent infectious diseases and Lawrence Livermore National Laboratory (“LLNL”) have agreed to collaborate on the development of a broad-spectrum coronavirus vaccine. This collaboration...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »